{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T13:28:49Z","timestamp":1787923729602,"version":"build-2784847793"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.msard.2026.107340","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T16:32:21Z","timestamp":1782318741000},"page":"107340","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Cell-type-specific Mendelian randomization analysis of brain single-nucleus eQTLs and neuromyelitis optica spectrum disorder risk"],"prefix":"10.1016","volume":"113","author":[{"given":"Hong","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songmin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leiyun","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixiang","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2026.107340_bib0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2017.05.018","article-title":"The HLA DRB1\u00d703:01 allele is associated with NMO regardless of the NMO-IgG status in Brazilian patients from Rio de Janeiro","volume":"310","author":"Alvarenga","year":"2017","journal-title":"J. Neuroimmunol."},{"issue":"5","key":"10.1016\/j.msard.2026.107340_bib0002","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S1474-4422(26)00084-0","article-title":"Identification of genetic risk loci associated with aquaporin 4-positive neuromyelitis optica spectrum disorder: a genome-wide association study","volume":"25","author":"Attfield","year":"2026","journal-title":"Lancet Neurol."},{"issue":"8","key":"10.1016\/j.msard.2026.107340_bib0003","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/s41593-022-01128-z","article-title":"Cell-type-specific cis-eQTLs in eight human brain cell types identify novel risk genes for psychiatric and neurological disorders","volume":"25","author":"Bryois","year":"2022","journal-title":"Nat. Neurosci."},{"issue":"5","key":"10.1016\/j.msard.2026.107340_bib0004","doi-asserted-by":"crossref","first-page":"5518","DOI":"10.1007\/s12035-024-04612-8","article-title":"Genetic insights into therapeutic targets for neuromyelitis optica spectrum disorders: a mendelian randomization study","volume":"62","author":"Cao","year":"2025","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.msard.2026.107340_bib0005","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s12974-021-02249-1","article-title":"Neuromyelitis optica spectrum disorders: from pathophysiology to therapeutic strategies","volume":"18","author":"Carnero Contentti","year":"2021","journal-title":"J. Neuroinflammation."},{"issue":"1","key":"10.1016\/j.msard.2026.107340_bib0006","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1038\/s41467-018-04332-3","article-title":"A whole-genome sequence study identifies genetic risk factors for neuromyelitis optica","volume":"9","author":"Estrada","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.msard.2026.107340_bib0007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/174720","article-title":"Epidemiology of neuromyelitis optica in the world: a systematic review and meta-analysis","volume":"2015","author":"Etemadifar","year":"2015","journal-title":"Mult. Scler. Int."},{"issue":"2","key":"10.1016\/j.msard.2026.107340_bib0008","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41588-024-02050-9","article-title":"Cell state-dependent allelic effects and contextual mendelian randomization analysis for human brain phenotypes","volume":"57","author":"Haglund","year":"2025","journal-title":"Nat. Genet."},{"issue":"4","key":"10.1016\/j.msard.2026.107340_bib0009","doi-asserted-by":"crossref","first-page":"5133","DOI":"10.1007\/s12035-024-04607-5","article-title":"Effect of l-carnitine level on the risk of neuromyelitis optica spectrum disorders: a two-sample mendelian randomization study","volume":"62","author":"Hu","year":"2025","journal-title":"Mol. Neurobiol."},{"issue":"3","key":"10.1016\/j.msard.2026.107340_bib0010","article-title":"eQTL analysis: a bridge from genome to mechanism","volume":"13","author":"Jia","year":"2026","journal-title":"Genes. Dis."},{"issue":"4","key":"10.1016\/j.msard.2026.107340_bib0011","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.4103\/0028-3886.355130","article-title":"Association of HLA DRB1-DQB1 haplotypes with the risk for neuromyelitis optica among South Indians","volume":"70","author":"Kanikannan","year":"2022","journal-title":"Neurol. India"},{"key":"10.1016\/j.msard.2026.107340_bib0012","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.msard.2019.02.002","article-title":"Intra-family phenotype variations in familial neuromyelitis optica spectrum disorders","volume":"30","author":"Lee","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"9451","key":"10.1016\/j.msard.2026.107340_bib0013","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.msard.2026.107340_bib0014","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0322098","article-title":"Potential drug targets for Neuromyelitis optica spectrum disorders (NMOSD): a mendelian randomization analysis","volume":"20","author":"Meng","year":"2025","journal-title":"PLoS. One"},{"issue":"4","key":"10.1016\/j.msard.2026.107340_bib0015","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/imm.12869","article-title":"The immunogenetics of neurological disease","volume":"153","author":"Misra","year":"2018","journal-title":"Immunology"},{"issue":"7","key":"10.1016\/j.msard.2026.107340_bib0016","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1056\/NEJMoa1900866","article-title":"Eculizumab in aquaporin-4-positive neuromyelitis optica spectrum disorder","volume":"381","author":"Pittock","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.msard.2026.107340_bib0017","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-69224-3","article-title":"Native American ancestry significantly contributes to neuromyelitis optica susceptibility in the admixed Mexican population","volume":"10","author":"Romero-Hidalgo","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.msard.2026.107340_bib0018","doi-asserted-by":"crossref","DOI":"10.1038\/s43586-021-00092-5","article-title":"Mendelian randomization","volume":"2","author":"Sanderson","year":"2022","journal-title":"Nat. Rev. Methods Primers."},{"issue":"10","key":"10.1016\/j.msard.2026.107340_bib0019","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/s41582-024-01014-1","article-title":"NMOSD and MOGAD: an evolving disease spectrum","volume":"20","author":"Uzawa","year":"2024","journal-title":"Nat. Rev. Neurol."},{"issue":"2","key":"10.1016\/j.msard.2026.107340_bib0020","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology."},{"issue":"22","key":"10.1016\/j.msard.2026.107340_bib0021","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1056\/NEJMoa1901747","article-title":"Trial of satralizumab in neuromyelitis optica spectrum disorder","volume":"381","author":"Yamamura","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.msard.2026.107340_bib0022","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/s41588-020-0682-6","article-title":"Phenome-wide mendelian randomization mapping the influence of the plasma proteome on complex diseases","volume":"52","author":"Zheng","year":"2020","journal-title":"Nat. Genet."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826003767?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826003767?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T12:51:03Z","timestamp":1787921463000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034826003767"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":22,"alternative-id":["S2211034826003767"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2026.107340","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cell-type-specific Mendelian randomization analysis of brain single-nucleus eQTLs and neuromyelitis optica spectrum disorder risk","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2026.107340","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107340"}}